Pradaxa
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Idarucizumab is the only anticoagulant reversal agent for dabigatran. Because of its high cost and limited data regarding…
Pradaxa (dabigatran) is a direct thrombin inhibitor approved for prevention of stroke and systemic embolism in patients with non…
Purpose:To critically appraise the evidence on dabigatran etexilate, Pradaxa, as an alternative to warfarin for stroke prevention…
The invention belongs to the field of medicinal chemistry and particularly relates to a method for preparing the impurity oxalate…
The invention relates to a method for preparing a pradaxa intermediate. The method is a chemical synthetic method, a synthesis…
Pharmaceutical companies don't have a particularly good reputation, for some very good reasons. But we can't let suspicions about…
The invention discloses a medicinal combination containing pradaxa or salt and hydrate thereof. The medicinal combination…
An analysis of complex examination of 110 patients with venous thromboembolism was made. The patients were separated into 2…